Teacher Retirement System Of Texas Incyte Corp Transaction History

Teacher Retirement System Of Texas

$20.2 Billion
Q3 2024

A detailed history of Teacher Retirement System Of Texas transactions in Incyte Corp stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 44,446 shares of INCY stock, worth $3.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,446

Previous 36,131 23.01%

Holding current value

$3.32 Million

Previous $2.19 Million 34.11%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $476,698 - $570,492	8,315 Added 23.01%	44,446 $2.94 Million
Q2 2024 Aug 09, 2024	SELL	$51.18 - $63.75 $367,574 - $457,852	-7,182 Reduced 16.58%	36,131 $2.19 Million
Q1 2024 May 06, 2024	SELL	$56.55 - $66.59 $67,746 - $79,774	-1,198 Reduced 2.69%	43,313 $2.47 Million
Q4 2023 Feb 07, 2024	SELL	$52.16 - $64.19 $296,216 - $364,535	-5,679 Reduced 11.32%	44,511 $2.8 Million
Q3 2023 Oct 31, 2023	BUY	$57.77 - $65.93 $48,931 - $55,842	847 Added 1.72%	50,190 $2.9 Million
Q2 2023 Jul 19, 2023	BUY	$60.95 - $75.51 $310,479 - $384,647	5,094 Added 11.51%	49,343 $3.07 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $1.69 Million - $2.06 Million	-24,004 Reduced 35.17%	44,249 $3.2 Million
Q4 2022 Feb 10, 2023	SELL	$67.18 - $84.11 $4.29 Million - $5.37 Million	-63,795 Reduced 48.31%	68,253 $5.48 Million
Q3 2022 Nov 03, 2022	BUY	$66.18 - $82.86 $2.04 Million - $2.55 Million	30,828 Added 30.46%	132,048 $8.8 Million
Q2 2022 Aug 09, 2022	SELL	$66.18 - $83.18 $7.79 Million - $9.79 Million	-117,705 Reduced 53.76%	101,220 $7.69 Million
Q1 2022 May 09, 2022	BUY	$66.02 - $79.71 $9.07 Million - $10.9 Million	137,350 Added 168.37%	218,925 $17.4 Million
Q4 2021 Feb 10, 2022	BUY	$63.34 - $74.11 $2.2 Million - $2.57 Million	34,738 Added 74.17%	81,575 $5.99 Million
Q3 2021 Nov 09, 2021	SELL	$68.67 - $84.02 $2.38 Million - $2.91 Million	-34,646 Reduced 42.52%	46,837 $3.22 Million
Q2 2021 Aug 05, 2021	SELL	$79.87 - $87.53 $1.67 Million - $1.84 Million	-20,966 Reduced 20.46%	81,483 $6.86 Million
Q1 2021 May 11, 2021	BUY	$76.02 - $100.5 $838,044 - $1.11 Million	11,024 Added 12.06%	102,449 $8.33 Million
Q4 2020 Feb 11, 2021	SELL	$80.74 - $97.7 $2.3 Million - $2.79 Million	-28,537 Reduced 23.79%	91,425 $7.95 Million
Q3 2020 Nov 02, 2020	BUY	$85.07 - $109.69 $5.29 Million - $6.83 Million	62,221 Added 107.76%	119,962 $10.8 Million
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $9.85 Million - $14.5 Million	-132,735 Reduced 69.69%	57,741 $6 Million
Q1 2020 May 05, 2020	SELL	$63.18 - $85.97 $4.32 Million - $5.88 Million	-68,389 Reduced 26.42%	190,476 $13.9 Million
Q4 2019 Feb 06, 2020	BUY	$73.04 - $95.72 $14.5 Million - $19 Million	198,221 Added 326.86%	258,865 $22.6 Million
Q3 2019 Oct 28, 2019	BUY	$72.82 - $86.52 $1.01 Million - $1.2 Million	13,833 Added 29.55%	60,644 $4.5 Million
Q2 2019 Aug 05, 2019	BUY	$73.52 - $88.7 $3.44 Million - $4.15 Million	46,811 New	46,811 $3.98 Million
Q4 2018 Mar 04, 2019	SELL	$58.5 - $69.94 $1.24 Million - $1.48 Million	-21,219 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$61.75 - $74.23 $1.45 Million - $1.75 Million	-23,554 Reduced 52.61%	21,219 $1.47 Million
Q2 2018 Aug 06, 2018	SELL	$60.85 - $83.98 $1.78 Million - $2.46 Million	-29,242 Reduced 39.51%	44,773 $3 Million
Q1 2018 May 08, 2018	SELL	$83.06 - $100.98 $420,449 - $511,160	-5,062 Reduced 6.4%	74,015 $6.17 Million
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $2.4 Million - $3 Million	-25,699 Reduced 24.53%	79,077 $7.49 Million
Q3 2017 Nov 06, 2017	BUY	$109.15 - $138.27 $11.4 Million - $14.5 Million	104,776	104,776 $12.2 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.

Account

Teacher Retirement System Of Texas Incyte Corp Transaction History